Increased Cyclooxygenase-2 Expression in Juvenile Polyposis Syndrome

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 1, 2009, Pages 93-97

  van Hattem, W Arnout ^a,b   Brosens, Lodewijk A A ^a   Marks, Susan Y ^b   Milne, Anya N A ^a   van Eeden, Susanne ^b   Iacobuzio Donahue, Christine A ^c   Ristimäki, Ari ^d   Giardiello, Francis M ^c   Offerhaus, G Johan A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; CCAAT ENHANCER BINDING PROTEIN BETA; CYCLOOXYGENASE 2; HU ANTIGEN; MESSENGER RNA;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CHILD; CLINICAL ARTICLE; COLON POLYPOSIS; CONTROLLED STUDY; CYTOPLASM; GENE MUTATION; GENETIC DISORDER; HUMAN; HUMAN TISSUE; JUVENILE POLYPOSIS SYNDROME; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE MICROARRAY;

ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; ANTIGENS, SURFACE; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CHILD; CHILD, PRESCHOOL; CYCLOOXYGENASE 2; GENE EXPRESSION PROFILING; HUMANS; INFANT; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA-BINDING PROTEINS;

EID: 58049216465     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.07.030     Document Type: Article

References (42)

1. Nugent K.P., Talbot I.C., Hodgson S.V., et al. Solitary juvenile polyps: not a marker for subsequent malignancy. Gastroenterology 105 (1993) 698-700
2. Jass J.R., Williams C.B., Bussey H.J., et al. Juvenile polyposis-a precancerous condition. Histopathology 13 (1988) 619-630
3. Aaltonen L.A., Jass J.R., and Howe J.R. Juvenile polyposis. Pathology and genetics of tumours of the digestive system (2000) 130-132
4. Giardiello F.M., Hamilton S.R., Kern S.E., et al. Colorectal neoplasia in juvenile polyposis or juvenile polyps. Arch Dis Child 66 (1991) 971-975
5. Brosens L.A., van Hattem A., Hylind L.M., et al. Risk of colorectal cancer in juvenile polyposis. Gut 56 (2007) 965-967
6. Howe J.R., Roth S., Ringold J.C., et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 280 (1998) 1086-1088
7. Howe J.R., Bair J.L., Sayed M.G., et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 28 (2001) 184-187
8. Aretz S., Stienen D., Uhlhaas S., et al. High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome. J Med Genet 44 (2007) 702-709
9. van Hattem W.A., Brosens L.A.A., de Leng W.W., et al. Large genomic deletions of SMAD4, BMPR1A or PTEN in juvenile polyposis. Gut 57 (2007) 623-627
10. Howe J., Haidle J., Lal G., et al. ENG mutations in MADH4/BMPR1A mutation negative patients with juvenile polyposis. Clin Genet 71 (2007) 91-92
11. Sweet K., Willis J., Zhou X.P., et al. Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. JAMA 294 (2005) 2465-2473
12. Massague J. TGFbeta signaling: receptors, transducers, and Mad proteins. Cell 85 (1996) 947-950
13. Sayed M.G., Ahmed A.F., Ringold J.R., et al. Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis. Ann Surg Oncol 9 (2002) 901-906
14. Friedl W., Uhlhaas S., Schulmann K., et al. Juvenile polyposis: massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriers. Hum Genet 111 (2002) 108-111
15. Handra-Luca A., Condroyer C., de Moncuit C., et al. Vessels' morphology in SMAD4 and BMPR1A-related juvenile polyposis. Am J Med Genet A 138 (2005) 113-117
16. Hla T., and Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A 89 (1992) 7384-7388
17. Tazawa R., Xu X.M., Wu K.K., et al. Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene. Biochem Biophys Res Commun 203 (1994) 190-199
18. Eberhart C.E., Coffey R.J., Radhika A., et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107 (1994) 1183-1188
19. Tsujii M., and DuBois R.N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83 (1995) 493-501
20. Brosens L.A., Iacobuzio-Donahue C.A., Keller J.J., et al. Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism. Clin Cancer Res 11 (2005) 4090-4096
21. Sengupta S., Jang B.C., Wu M.T., et al. The RNA-binding protein HuR regulates the expression of cyclooxygenase-2. J Biol Chem 278 (2003) 25227-25233
22. Fan X.C., and Steitz J.A. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J 17 (1998) 3448-3460
23. Umek R.M., Friedman A.D., and McKnight S.L. CCAAT-enhancer binding protein: a component of a differentiation switch. Science 251 (1991) 288-292
24. Eisinger A.L., Nadauld L.D., Shelton D.N., et al. The APC tumor suppressor gene regulates expression of cyclooxygenase-2 by a mechanism that involves retinoic acid. Biol Chem 281 (2006) 20474-20482
25. Rask K., Thorn M., Ponten F., et al. Increased expression of the transcription factors CCAAT-enhancer binding protein-beta (C/EBBeta) and C/EBzeta (CHOP) correlate with invasiveness of human colorectal cancer. Int J Cancer 86 (2000) 337-343
26. Wang W., Furneaux H., Cheng H., et al. HuR regulates p21 mRNA stabilization by UV light. Mol Cell Biol 20 (2000) 760-769
27. Milne A.N., Carvalho R., Morsink F.M., et al. Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers. Mod Pathol 19 (2006) 564-572
28. Buskens C.J., Van Rees B.P., Sivula A., et al. Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus. Gastroenterology 122 (2002) 1800-1807
29. Erkinheimo T.L., Lassus H., Sivula A., et al. Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma. Cancer Res 63 (2003) 7591-7594
30. Giardiello F.M., Hamilton S.R., Krush A.J., et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328 (1993) 1313-1316
31. Steinbach G., Lynch P.M., Phillips R.K., et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342 (2000) 1946-1952
32. Kurland J.E., Beck S.E., Solomon C.J., et al. Cyclooxygenase-2 expression in polyps from a patient with juvenile polyposis syndrome with mutant BMPR1A. J Pediatr Gastroenterol Nutr 44 (2007) 318-325
33. Brazowski E., Rozen P., Misonzhnick-Bedny F., et al. Characteristics of familial juvenile polyps expressing cyclooxygenase-2. Am J Gastroenterol 100 (2005) 130-138
34. Haramis A.P., Begthel H., van den Born M., et al. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 303 (2004) 1684-1686
35. Takaku K., Miyoshi H., Matsunaga A., et al. Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice. Cancer Res 59 (1999) 6113-6117
36. Hohenstein P., Molenaar L., Elsinga J., et al. Serrated adenomas and mixed polyposis caused by a splice acceptor deletion in the mouse Smad4 gene. Genes Chromosomes Cancer 36 (2003) 273-282
37. He X.C., Zhang J., Tong W.G., et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet 36 (2004) 1117-1121
38. Baron J.A., Sandler R.S., Bresalier R.S., et al. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 131 (2006) 1674-1682
39. Bertagnolli M.M., Eagle C.J., Zauber A.G., et al. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 355 (2006) 873-884
40. Brennan C.M., and Steitz J.A. HuR and mRNA stability. Cell Mol Life Sci 58 (2001) 266-277
41. Lopez de Silanes I., Fan J., Yang X., et al. Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene 22 (2003) 7146-7154
42. Denkert C., Koch I., von Keyserlingk N., et al. Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. Mod Pathol 19 (2006) 1261-1269